Related references
Note: Only part of the references are listed.The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder
Taro Kishi et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Serotonin receptors involved in antidepressant effects
Francesc Artigas
PHARMACOLOGY & THERAPEUTICS (2013)
Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions
Albert Ferres-Coy et al.
PSYCHOPHARMACOLOGY (2013)
Preclinical and clinical characterization of the selective 5-HT1A receptor antagonist DU-125530 for antidepressant treatment
M. C. Scorza et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons
Laia Llado-Pelfort et al.
CEREBRAL CORTEX (2012)
Increased Serotonin-1A (5-HT1A) Autoreceptor Expression and Reduced Raphe Serotonin Levels in Deformed Epidermal Autoregulatory Factor-1 (Deaf-1) Gene Knock-out Mice
Margaret Czesak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects
A. Bortolozzi et al.
MOLECULAR PSYCHIATRY (2012)
In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat
Laia Llado-Pelfort et al.
PSYCHOPHARMACOLOGY (2012)
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
M. Horiguchi et al.
PSYCHOPHARMACOLOGY (2012)
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
A. Mork et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Competitive interaction of 5-HT1A receptors with G-protein subtypes in CHO cells demonstrated by RNA interference
Isabelle Rauly-Lestienne et al.
CELLULAR SIGNALLING (2011)
Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease
Yukihiro Ohno
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Cost of disorders of the brain in Europe 2010
Anders Gustavsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Can We Really Accelerate and Enhance the Selective Serotonin Reuptake Inhibitor Antidepressant Effect? A Randomized Clinical Trial and a Meta-Analysis of Pindolol in Nonresistant Depression
Maria J. Portella et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Serotonin-1A Autoreceptors Are Necessary and Sufficient for the Normal Formation of Circuits Underlying Innate Anxiety
Jesse W. Richardson-Jones et al.
JOURNAL OF NEUROSCIENCE (2011)
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Gregory V. Carr et al.
PSYCHOPHARMACOLOGY (2011)
Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
Adrian Newman-Tancredi et al.
PSYCHOPHARMACOLOGY (2011)
Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders
Adrian Newman-Tancredi
NEUROPSYCHIATRY (2011)
The prefrontal cortex: a target for antipsychotic drugs
F. Artigas
ACTA PSYCHIATRICA SCANDINAVICA (2010)
Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations
Ramin V. Parsey et al.
BIOLOGICAL PSYCHIATRY (2010)
Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors
L. Llado-Pelfort et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
5-HT1A receptor-regulated signal transduction pathways in brain
Abigail M. Polter et al.
CELLULAR SIGNALLING (2010)
F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists
Ronan Depoortere et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors
Analia Bortolozzi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review
R. Whale et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
5-HT1A Autoreceptor Levels Determine Vulnerability to Stress and Response to Antidepressants
Jesse W. Richardson-Jones et al.
NEURON (2010)
Synchronized Activity between the Ventral Hippocampus and the Medial Prefrontal Cortex during Anxiety
Avishek Adhikari et al.
NEURON (2010)
The serotonin1A receptor gene as a genetic and prenatal maternal environmental factor in anxiety
G. Gleason et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist
A. Newman-Tancredi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors
Pablo Vazquez-Borsetti et al.
CEREBRAL CORTEX (2009)
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist
Danijela Piskulic et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Subchronic Effects of Phencyclidine on Dopamine and Serotonin Receptors: Implications for Schizophrenia
Yong Kee Choi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression
C. D. Neff et al.
MOLECULAR PSYCHIATRY (2009)
Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
Rainald Moessner et al.
PHARMACOGENETICS AND GENOMICS (2009)
5-HT1A receptor function in major depressive disorder
Jonathan Savitz et al.
PROGRESS IN NEUROBIOLOGY (2009)
The role of 5-HT1A receptors in learning and memory
Sven Ove Ogren et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
Herbert Y. Meltzer et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Serotonin 5-HT1A receptor binding in people with panic disorder:: positron emission tomography study
Jon R. Nash et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
5-HT1A receptor, an old target for new therapeutic agents
Enza Lacivita et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells
Peter Heusler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment
Julian de Almeida et al.
JOURNAL OF NEUROCHEMISTRY (2008)
α-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice
Luisa Lo Iacono et al.
JOURNAL OF NEUROSCIENCE (2008)
High-efficacy 5-HT1A Agonists for antidepressant treatment:: A renewed opportunity
Jean Louis Maurel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Serotonin4 (5-HT4) receptor Agonists are putative antidepressants with a rapid onset of action
Guillaume Lucas et al.
NEURON (2007)
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia:: A randomized, double-blind, placebo-controlled study
Tomiki Sumiyoshi et al.
SCHIZOPHRENIA RESEARCH (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Reduced serotonin-1A receptor binding in social anxiety disorder
Rupert R. Lanzenberger et al.
BIOLOGICAL PSYCHIATRY (2007)
F15063, a compound with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (III) Activity in models of cognition and negative symptoms
R. Depoortere et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain
A. Bortolozzi et al.
PSYCHOPHARMACOLOGY (2007)
5-HT1A receptors and memory
Alfredo Meneses et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
The anxiety-like phenotype of 5-HT1A receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system
S. Bruening et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist
L Díaz-Mataix et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Medication augmentation after the failure of SSRIs for depression
MH Trivedi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: A placebo controlled study
MH Pollack et al.
BIOLOGICAL PSYCHIATRY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
5-HT1a receptor antagonists block perforant path-dentate LTP induced in novel, but not familiar, environments
CD Sanberg et al.
LEARNING & MEMORY (2006)
Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety
GM Sullivan et al.
BIOLOGICAL PSYCHIATRY (2005)
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity:: Role in atypical antipsychotic action
L Díaz-Mataix et al.
JOURNAL OF NEUROSCIENCE (2005)
State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice
JA Gordon et al.
JOURNAL OF NEUROSCIENCE (2005)
Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Treatment of cerebellar ataxia with 5-HT1A agonist
A Takei et al.
CEREBELLUM (2005)
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: Involvement of serotonin and GABA
MV Puig et al.
CEREBRAL CORTEX (2005)
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635
Z Bhagwagar et al.
MOLECULAR PSYCHIATRY (2004)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and α1-adrenoceptors
K Tachibana et al.
NEUROSCIENCE LETTERS (2004)
Decreased 5-HT1A receptor binding in amygdala of schizophrenia
F Yasuno et al.
BIOLOGICAL PSYCHIATRY (2004)
Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone
M Banasr et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex
M Amargós-Bosch et al.
CEREBRAL CORTEX (2004)
Reduced serotonin type 1A receptor binding in panic disorder
A Neumeister et al.
JOURNAL OF NEUROSCIENCE (2004)
Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype:: Evidence for genetic modifiers in the 5-HT-mediated regulation of GABAA receptors
SJ Bailey et al.
JOURNAL OF NEUROSCIENCE (2004)
Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat
M Riad et al.
JOURNAL OF NEUROSCIENCE (2004)
Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors
H Kusserow et al.
MOLECULAR BRAIN RESEARCH (2004)
Expression of Serotonin1A and Serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex
N Santana et al.
CEREBRAL CORTEX (2004)
Global burden of depressive disorders in the year 2000
TB Üstün et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Regional dissociations within the hippocampus - memory and anxiety
DM Bannerman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study
S Dilger et al.
NEUROSCIENCE LETTERS (2003)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
The neurobiology and control of anxious states
MJ Millan
PROGRESS IN NEUROBIOLOGY (2003)
A meta-analysis of the efficacy of second-generation antipsychotics
JM Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-manalysis
S Leucht et al.
LANCET (2003)
Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests
AA Shah et al.
BRAIN RESEARCH (2003)
Occupancy of 5-HT1A receptors by clozapine in the primate brain:: a PET study
YH Chou et al.
PSYCHOPHARMACOLOGY (2003)
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs
N Singewald et al.
BIOLOGICAL PSYCHIATRY (2003)
Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory
F Yasuno et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Is there a role for 5-HT1A agonists in the treatment of depression?
P Blier et al.
BIOLOGICAL PSYCHIATRY (2003)
In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity
B Astier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Fluvoxamine suppresses the long-term potentiation in the hippocampal CAl field of anesthetized rats:: an effect mediated via 5-HT1A receptors
T Kojima et al.
BRAIN RESEARCH (2003)
Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats
CA Winstanley et al.
PSYCHOPHARMACOLOGY (2003)
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
A Holmes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Behavioral and neurochemical effects of 5-{4-[4-(5-cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843):: A combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine1A receptor partial agonist
ME Page et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
A Adell et al.
BRAIN RESEARCH REVIEWS (2002)
Reduced fear expression after lesions of the ventral hippocampus
KG Kjelstrup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats
M Kalinichev et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635
J Tauscher et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
C Gross et al.
NATURE (2002)
Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates
M Champoux et al.
MOLECULAR PSYCHIATRY (2002)
Functional MRI changes during panic anticipation and imagery exposure
A Bystritsky et al.
NEUROREPORT (2001)
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment
T Sumiyoshi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Inverse relationship between serotonin 5-HT1A receptor binding and anxiety:: a [11C]WAY-100635 PET investigation in healthy volunteers
J Tauscher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
An open study of buspirone augmentation of neuroleptics in patients with schizophrenia
P Sirota et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Different effects of anxiolytic agents, diazepam and 5-HT1A agonist tandospirone, on hippocampal long-term potentiation in vivo
K Mori et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Targeted gene mutation approaches to the study of anxiety-like behavior in mice
A Holmes
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
Differential occupancy of somatodendritic and postsynaptic 5HT1A receptors by pindolol:: A dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans
D Martinez et al.
NEUROPSYCHOPHARMACOLOGY (2001)
5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation:: a possible mechanism of atypical antipsychotic-induced cortical dopamine release
J Ichikawa et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635
I Hervas et al.
NEUROPSYCHOPHARMACOLOGY (2001)
An integrative theory of prefrontal cortex function
EK Miller et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?
RA Bantick et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2001)
Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors
Z Sarnyai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release
JM Casanovas et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
H Rollema et al.
BIOLOGICAL PSYCHIATRY (2000)
Maternal care, hippocampal synaptogenesis and cognitive development in rats
D Liu et al.
NATURE NEUROSCIENCE (2000)
Adult brain neurogenesis and psychiatry: a novel theory of depression
BL Jacobs et al.
MOLECULAR PSYCHIATRY (2000)
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635 -: Effects of depression and antidepressant treatment
PA Sargent et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
SPECT [I-123]Iomazenil measurement of the benzodiazepine receptor in panic disorder
JD Bremner et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
